154 related articles for article (PubMed ID: 34409243)
1. Rapid and Deep Remission Induced by Blinatumomab for CD19-Positive Chronic Myeloid Leukemia in Lymphoid Blast Phase.
Patel SA; Bledsoe JR; Higgins AW; Hutchinson L; Gerber JM
JCO Precis Oncol; 2021 Jul; 5():. PubMed ID: 34409243
[No Abstract] [Full Text] [Related]
2. Gemtuzumab-ozogamicin and blinatumomab as treatment for refractory mixed-phenotype blast crisis in chronic myeloid leukaemia.
Ovilla-Martinez R; Weber Sánchez LA; Cota-Rangel X; Baez-Islas PE
BMJ Case Rep; 2021 Nov; 14(11):. PubMed ID: 34764108
[TBL] [Abstract][Full Text] [Related]
3. Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome.
Druker BJ; Sawyers CL; Kantarjian H; Resta DJ; Reese SF; Ford JM; Capdeville R; Talpaz M
N Engl J Med; 2001 Apr; 344(14):1038-42. PubMed ID: 11287973
[TBL] [Abstract][Full Text] [Related]
4. FTY720, a new alternative for treating blast crisis chronic myelogenous leukemia and Philadelphia chromosome-positive acute lymphocytic leukemia.
Neviani P; Santhanam R; Oaks JJ; Eiring AM; Notari M; Blaser BW; Liu S; Trotta R; Muthusamy N; Gambacorti-Passerini C; Druker BJ; Cortes J; Marcucci G; Chen CS; Verrills NM; Roy DC; Caligiuri MA; Bloomfield CD; Byrd JC; Perrotti D
J Clin Invest; 2007 Sep; 117(9):2408-21. PubMed ID: 17717597
[TBL] [Abstract][Full Text] [Related]
5. Different suppression of Ph1 positive hemopoiesis induced by intensive chemotherapy in lymphoid and myeloid blast crisis of CML.
Guerrasio A; Martinelli G; Ambrosetti A; Falda M; Paolino F; Rege-Cambrin G; Rosso C; Pignatti PF; Gasparini P; Perona G
Haematologica; 1991; 76(2):126-30. PubMed ID: 1937170
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy and imatinib-induced molecular remission in lymphoid blast crisis after 20 years of "untreated" chronic myeloid leukemia.
Koca E; Sevimli F; Cetiner D; Haznedaroglu IC; Sayinalp N; Büyükasik Y; Goker H; Ozcebe O
Am J Hematol; 2007 Apr; 82(4):333. PubMed ID: 17094091
[No Abstract] [Full Text] [Related]
7. Very long survival in complete cytogenetic remission in an adolescent with lymphoid blast crisis of chronic myeloid leukemia after treatment with intensive ALL-directed chemotherapy combined with continuous imatinib.
Maschan A; Novichkova G; Miakova N; Persiantseva M
Pediatr Blood Cancer; 2016 Dec; 63(12):2243-2245. PubMed ID: 27434016
[TBL] [Abstract][Full Text] [Related]
8. T-lymphoid or T/myeloid blast phase of chronic myeloid leukemia in the era of tyrosine kinase inhibitor therapy: a report of 14 cases.
Gong Z; Xie W; Wang W; Chen Z; Xu J; Yuan J; Zhou Y; Wang D; Medeiros LJ; Hu S
Int J Lab Hematol; 2017 Apr; 39(2):e45-e50. PubMed ID: 27863007
[No Abstract] [Full Text] [Related]
9. Hematopoietic stem cell involvement in
Nagel I; Bartels M; Duell J; Oberg HH; Ussat S; Bruckmueller H; Ottmann O; Pfeifer H; Trautmann H; Gökbuget N; Caliebe A; Kabelitz D; Kneba M; Horst HA; Hoelzer D; Topp MS; Cascorbi I; Siebert R; Brüggemann M
Blood; 2017 Nov; 130(18):2027-2031. PubMed ID: 28827408
[TBL] [Abstract][Full Text] [Related]
10. Sudden lymphoid blast crisis after tyrosine kinase inhibitor discontinuation in chronic phase chronic myeloid leukemia: cautionary tales for appropriate molecular monitoring.
Bataller A; Haddad FG; Issa GC; Sasaki K; Jabbour E; Borthakur G; Ferrajoli A; Short NJ
Leuk Lymphoma; 2023 Mar; 64(3):746-749. PubMed ID: 36657414
[No Abstract] [Full Text] [Related]
11. Imatinib activity in vitro in tumor cells from patients with chronic myeloid leukemia in chronic phase and blast crisis.
Olsson-Strömberg U; Aleskog A; Björnberg A; Höglund M; Simonsson B; Bengtsson M; Barbany G; Larsson R; Lindhagen E
Anticancer Drugs; 2006 Jul; 17(6):631-9. PubMed ID: 16917208
[TBL] [Abstract][Full Text] [Related]
12. [Efficacy of imatinib mesylate, a specific inhibitor of BCR/ABL tyrosine kinase, on chronic myeloid leukemia in blast phase].
Zhang GC; Zheng D; Li QH; Li XH; Cai CC; Luo SK; Li J; Peng AH; Tong XZ; Tan EX; Hong WD
Ai Zheng; 2004 Dec; 23(12):1696-9. PubMed ID: 15601563
[TBL] [Abstract][Full Text] [Related]
13. Isolated central nervous system relapse after nine years of complete molecular remission in a lymphoid blast crisis of chronic myeloid leukemia treated with imatinib.
Breccia M; Santopietro M; Cannella L; Federico V; Loglisci G; Serrao A; Petrucci L; Salaroli A; Nanni M; De Propris MS; Diverio D; Alimena G
Leuk Res; 2011 Jun; 35(6):e91-2. PubMed ID: 21316103
[No Abstract] [Full Text] [Related]
14. Lymphoid blast crisis at the onset of chronic myelogenous leukaemia: molecular evidence.
Roman J; Andres P; Jimenez MA; Torres A
Br J Haematol; 1994 Jul; 87(3):624-6. PubMed ID: 7993807
[TBL] [Abstract][Full Text] [Related]
15. [Rapamycin for myeloid blast crisis in refractory chronic myeloid leukemia with imatinib-resistance].
Xie J; Zhang X; Fang BZ
Zhonghua Xue Ye Xue Za Zhi; 2011 Aug; 32(8):553-4. PubMed ID: 22338181
[No Abstract] [Full Text] [Related]
16. Dasatinib combined with weekly administration of vincristine as effective therapy in sudden or resistant Ph+ lymphoid blast crisis of chronic myeloid leukaemia.
Breccia M; Serrao A; Salaroli A; Loglisci G; Zacheo I; Alimena G
Br J Haematol; 2012 Dec; 159(5):612-3. PubMed ID: 23043319
[No Abstract] [Full Text] [Related]
17. Combined inhibition of β-catenin and Bcr-Abl synergistically targets tyrosine kinase inhibitor-resistant blast crisis chronic myeloid leukemia blasts and progenitors in vitro and in vivo.
Zhou H; Mak PY; Mu H; Mak DH; Zeng Z; Cortes J; Liu Q; Andreeff M; Carter BZ
Leukemia; 2017 Oct; 31(10):2065-2074. PubMed ID: 28321124
[TBL] [Abstract][Full Text] [Related]
18. Dasatinib induces complete hematologic and cytogenetic responses in patients with imatinib-resistant or -intolerant chronic myeloid leukemia in blast crisis.
Cortes J; Rousselot P; Kim DW; Ritchie E; Hamerschlak N; Coutre S; Hochhaus A; Guilhot F; Saglio G; Apperley J; Ottmann O; Shah N; Erben P; Branford S; Agarwal P; Gollerkeri A; Baccarani M
Blood; 2007 Apr; 109(8):3207-13. PubMed ID: 17185463
[TBL] [Abstract][Full Text] [Related]
19. Long duration priapism in blast crisis of chronic myeloid leukemia.
Dogra PN; Kumar P; Goel R; Dash SC
J Assoc Physicians India; 2004 Feb; 52():170. PubMed ID: 15656063
[No Abstract] [Full Text] [Related]
20. Pathobiology of lymphoid and myeloid blast crisis and management issues.
Ilaria RL
Hematology Am Soc Hematol Educ Program; 2005; ():188-94. PubMed ID: 16304379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
